Dow Jones

40 003,59

0,34%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
AMEX
Calidi Biotherapeutics Inc (CLDI)
Calidi Biotherapeutics Inc (CLDI) Actualités

CLDI

Calidi Biotherapeutics (CLDI)

Calidi Biotherapeutics Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:AMEX:CLDI

Date	Heure	Source	Titre	Symbole	Société
14/05/2024	22h05	Business Wire	Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results	AMEX:CLDI	Calidi Biotherapeutics Inc
01/05/2024	13h00	Business Wire	Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting	AMEX:CLDI	Calidi Biotherapeutics Inc
23/04/2024	13h00	Business Wire	Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24	AMEX:CLDI	Calidi Biotherapeutics Inc
19/04/2024	22h05	Business Wire	Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering	AMEX:CLDI	Calidi Biotherapeutics Inc
16/04/2024	14h31	Business Wire	Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering	AMEX:CLDI	Calidi Biotherapeutics Inc
09/04/2024	13h00	Business Wire	Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024	AMEX:CLDI	Calidi Biotherapeutics Inc
15/03/2024	21h05	Business Wire	Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results	AMEX:CLDI	Calidi Biotherapeutics Inc
11/03/2024	12h00	Business Wire	Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer	AMEX:CLDI	Calidi Biotherapeutics Inc
12/02/2024	13h00	Business Wire	Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference	AMEX:CLDI	Calidi Biotherapeutics Inc
08/01/2024	13h00	Business Wire	Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board	AMEX:CLDI	Calidi Biotherapeutics Inc
13/12/2023	13h00	Business Wire	Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit	AMEX:CLDI	Calidi Biotherapeutics Inc
12/12/2023	13h00	Business Wire	Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directors	AMEX:CLDI	Calidi Biotherapeutics Inc
20/11/2023	13h00	Business Wire	Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones	AMEX:CLDI	Calidi Biotherapeutics Inc
14/11/2023	22h05	Business Wire	Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results	AMEX:CLDI	Calidi Biotherapeutics Inc
03/11/2023	12h00	Business Wire	Calidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023)	AMEX:CLDI	Calidi Biotherapeutics Inc
01/11/2023	12h00	Business Wire	Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment	AMEX:CLDI	Calidi Biotherapeutics Inc
30/10/2023	12h00	Business Wire	Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer	AMEX:CLDI	Calidi Biotherapeutics Inc
10/10/2023	13h00	Business Wire	Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023	AMEX:CLDI	Calidi Biotherapeutics Inc
13/09/2023	11h50	Business Wire	Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies	AMEX:CLDI	Calidi Biotherapeutics Inc